Biotech Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS May 12, 2025
Biotech Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 May 11, 2025
Biotech Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025 May 10, 2025
Biotech Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress May 10, 2025
Biotech Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum May 10, 2025
Biotech IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel May 9, 2025
Biotech Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China May 9, 2025
Biotech NextGen Jane Awarded Second NIH Grant For The Evaluation of a Non-Invasive Endometriosis Diagnostic May 8, 2025
Search
Biotech
May 12, 2025
May 11, 2025
May 10, 2025
May 10, 2025
May 10, 2025
May 9, 2025
May 9, 2025
May 9, 2025
May 8, 2025
May 8, 2025
